Filings · News reference

Grace Therapeutics Files Prospectus For Offering 4.762M Common Shares On Behalf Of Selling Shareholders

Aug 24, 2026, 8:12 PMBenzinga Newsdesk

https://www.sec.gov/Archives/edgar/data/1444192/000114036126034189/ny20080485x1_s3.htm

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 13, 2026, 12:23 PMBenzinga Newsdesk
Grace Therapeutics Q1 EPS $(0.91) Misses $(0.18) Estimate
Grace Therapeutics (NASDAQ:GRCE) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.18) by 405.56 percent. This is a 333.33 percent decrease over losses of $(0.21) per
Read original at benzinga
GRCE
SEC EDGARAug 13, 2026, 12:01 PMSEC EDGAR
8-K filing — Grace Therapeutics, Inc. (GRCE)
Filed: 2026-08-13 AccNo: 0001140361-26-032644 Size: 312 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar
GRCE
BenzingaAug 5, 2026, 6:53 AMBenzinga Newsdesk
Reported Earlier, Grace Therapeutics Prices Private Placement Of 4,761,904 Shares At $2.10 Per Share To Fund GTx-104 Manufacturing And Regulatory Work
Read original at benzinga
GRCE